Description: Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Home Page: www.alcon.com
0A0D Technical Analysis
Chemin de Blandonnet 8
Geneva,
1214
Switzerland
Phone:
41 589 112 110
Officers
| Name | Title |
|---|---|
| Mr. F. Michael Ball | Executive Chairman |
| Mr. David J. Endicott | CEO & Director |
| Mr. Arthur B. Cummings M.D. | Executive Director |
| Mr. Timothy C. Stonesifer | Senior VP & CFO |
| Mr. Ian Bell | Senior VP & COO |
| Margaret Buckley | Chief Accounting Officer |
| Dr. Franck Leveiller | SVP of Global Research & Development and Chief Scientific Officer |
| Mr. Muru Murugappan | Senior VP and Chief Information & Transformation Officer |
| Mr. Royce R. Bedward J.D. | Senior VP, General Counsel & Corporate Secretary |
| Ms. Kimberly Martin | Senior VP, Chief HR Officer & Corporate Communications |
Exchange: LSE
Country: GB : United Kingdom of Great Britain and Northern Ireland
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.7875 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.5409 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 25000 |